Franklin Resources’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Franklin Resources’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20	Closed	-$79K	–	2399
2022 Q3	$79K	Hold	20	–	–	﹤0.01%	2142
2022 Q2	$52K	Sell	20 -9	-31%	-$23.4K	﹤0.01%	2241
2022 Q1	$94K	Hold	29	–	–	﹤0.01%	2303
2021 Q4	$183K	Hold	29	–	–	﹤0.01%	2255
2021 Q3	$272K	Buy	+29	New	+$249K	﹤0.01%	2120
2018 Q3	–	Sell	-1	Closed	-$41K	–	1551
2018 Q2	$41K	Hold	1	–	–	﹤0.01%	1463
2018 Q1	$33K	Hold	1	–	–	﹤0.01%	1499
2017 Q4	$139K	Hold	1	–	–	﹤0.01%	1492
2017 Q3	$137K	Hold	1	–	–	﹤0.01%	1467
2017 Q2	$75K	Buy	+1	New	+$140K	﹤0.01%	1489
2017 Q1	–	Hold	0	–	–	–	1478
2016 Q4	–	Hold	0	–	–	–	1461
2016 Q3	–	Hold	0	–	–	–	1484
2016 Q2	–	Hold	0	–	–	–	1495
2016 Q1	–	Hold	0	–	–	–	1502
2015 Q4	–	Hold	0	–	–	–	1559
2015 Q3	–	Hold	0	–	–	–	1557
2015 Q2	–	Hold	0	–	–	–	1578
2015 Q1	–	Hold	0	–	–	–	1570

Other funds holding SEEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Franklin Resources's SEEL Position: Q4 2022 in Review

Franklin Resources sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 20 shares — an estimated $79K sold.

Franklin Resources first reported a position in SEEL in Q2 2017 and held it in 10 quarters. The position peaked at $272K in Q3 2021. 63 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.

Franklin Resources reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Franklin Resources sold 20 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $79K.
Franklin Resources first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Franklin Resources's Seelos Therapeutics, Inc. Common Stock position peaked at $272K in Q3 2021.
63 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.